www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
 PRESS RELEASES
ANNUAL REPORTS
CONTACT

 
 
  To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
 

[ 2010 | 2009 | 2008 ]

DECEMBER 04, 2008
AUXILIUM PHARMACEUTICALS, INC. AND CPEX PHARMACEUTICALS, INC. FILE LAWSUIT AGAINST UPSHER-SMITH LABORATORIES, INC. FOR INFRINGEMENT OF TESTIM® PATENT

NOVEMBER 17, 2008
CPEX PHARMACEUTICALS ANNOUNCES INITIATION OF PHASE II TRIAL FOR UROLOGY INDICATION BY SERENITY PHARMACEUTICALS

NOVEMBER 13, 2008
CPEX PHARMACEUTICALS ANNOUNCES PRESENTATION OF ABSTRACT AND POSTER AT THE EIGHTH ANNUAL DIABETES TECHNOLOGY MEETING

NOVEMBER 10, 2008
CPEX PHARMACEUTICALS ANNOUNCES PUBLICATION IN JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

NOVEMBER 06, 2008
CPEX PHARMACEUTICALS TO PRESENT AT RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE

NOVEMBER 06, 2008
CPEX PHARMACEUTICALS REPORTS THIRD-QUARTER 2008 FINANCIAL RESULTS

OCTOBER 24, 2008
AUXILIUM PHARMACEUTICALS, INC. AND CPEX PHARMACEUTICALS, INC. RECEIVE PARAGRAPH IV CERTIFICATION NOTICE FROM UPSHER-SMITH LABORATORIES FOR TESTIM®

AUGUST 14, 2008
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2008 FINANCIAL RESULTS

AUGUST 12, 2008
CPEX PHARMACEUTICALS SIGNS CONTRACT MANUFACTURING AGREEMENT
SECURES MANUFACTURING CAPACITY FOR INTRANASAL INSULIN PRODUCT CANDIDATE CURRENTLY IN PHASE II CLINICAL TRIALS

AUGUST 04, 2008
CPEX PHARMACEUTICALS AND SERENITY PHARMACEUTICALS ANNOUNCE COLLABORATION ON DRUG CANDIDATE FOR UROLOGY INDICATION
SERENITY FILES IND FOR INTRANASAL DRUG EMPLOYING CPEX’S DELIVERY PLATFORM

JULY 01, 2008
CPEX PHARMACEUTICALS SHARES TO BEGIN TRADING TODAY FOLLOWING SPIN-OFF FROM BENTLEY PHARMACEUTICALS

If you are interested in receiving an investor packet, please call us at 603.658.6100.

 
 
 
AUGUST 09, 2010
CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS
 
MAY 26, 2010
CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS
 
MAY 06, 2010
CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101